Advancing therapy through clearer electroneurograms recordings
Our technology aims to address technological deficiencies present in the current ENG recording systems through high-speed recording of biomedical signals, ability to preserve valuable clinical information and optimization of therapy delivery through closed feedback loop.
Our first product focuses on improving safety and efficacy of renal denervation procedures.
Our Leadership
Partnerships
Mayo Clinic
Under the terms of our 10-year collaboration agreement, we are pursuing several projects that include research studies and clinical validation. Our goal is to develop advanced clinical features and applications built around high fidelity and detailed signal analysis and to explore new disease areas and applications leading to joint IP filings and licensing opportunities.
OUR PARTNER: SAMUEL J. ASIRVATHAM, M.D., PH.D., Vice-Chair, Innovation and Medical Director, Electrophysiology Laboratory, Mayo Clinic
University of Minnesota
Our objective is to develop novel therapies to treat sympathetic nervous system disease. The studies run under this program are expected to form a foundation for developing a new platform technology to address disorders of the autonomic nervous system.
OUR PARTNER: JOHN W. OSBORN, PH.D., Director, Minnesota Consortium for Autonomic Neuromodulation (MCAN)